The CYP17A1 inhibitor abiraterone exhibits estrogen receptor agonist activity in breast cancer.
about
The CYP17A1 inhibitor abiraterone exhibits estrogen receptor agonist activity in breast cancer.
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The CYP17A1 inhibitor abirater ...... ist activity in breast cancer.
@ast
The CYP17A1 inhibitor abirater ...... ist activity in breast cancer.
@en
The CYP17A1 inhibitor abirater ...... ist activity in breast cancer.
@nl
type
label
The CYP17A1 inhibitor abirater ...... ist activity in breast cancer.
@ast
The CYP17A1 inhibitor abirater ...... ist activity in breast cancer.
@en
The CYP17A1 inhibitor abirater ...... ist activity in breast cancer.
@nl
prefLabel
The CYP17A1 inhibitor abirater ...... ist activity in breast cancer.
@ast
The CYP17A1 inhibitor abirater ...... ist activity in breast cancer.
@en
The CYP17A1 inhibitor abirater ...... ist activity in breast cancer.
@nl
P2093
P2860
P1476
The CYP17A1 inhibitor abirater ...... ist activity in breast cancer.
@en
P2093
Cameron P Capper
James M Rae
José M Larios
Matthew J Sikora
Michael D Johnson
P2860
P2888
P356
10.1007/S10549-016-3774-3
P407
P577
2016-04-15T00:00:00Z
P6179
1022921411